Viatar CTC Solutions Announces Participation in Upcoming Conferences
LOWELL, Mass., May 21, 2015 (GLOBE NEWSWIRE) -- Viatar CTC Solutions Inc. (OTC Pink:VRTT), a medical technology company focused on the treatment of patients with metastatic cancer, today announced that its Chairman and CEO, Ilan Reich, will provide a corporate overview during presentations at the following upcoming investor conferences.
| Event: SeeThruEquity 4th Annual Microcap Investor Conference |
| Date: May 28, 2015 |
| Time: 9:30-10:00AM ET |
| Location: Convene Grand Central, 101 Park Avenue, New York City |
| Event: 2015 Marcum MicroCap Conference |
| Date: May 28, 2015 |
| Time: 3:00-3:30PM ET |
| Location: Grand Hyatt Hotel, 109 E 42nd St, New York City |
About Viatar CTC Solutions Inc.
Viatar CTC Solutions Inc. is a medical technology company focused on the treatment of patients with metastatic cancer. The company's lead product, the ViatarTM Therapeutic Oncopheresis System, removes circulating tumor cells from whole blood using label-free cross-flow filtration. Pending regulatory approval targeted for 2016, it will be used as a periodic therapy to improve overall survival for a wide range of solid tumor types such as lung, breast, colon, prostate and gastric cancers.
This proprietary technology also powers the company's liquid biopsy products, which are collection systems for use by genetic testing companies, researchers and medical oncologists that provide a greater quantity and purity of circulating tumor cells for their molecular analysis and personalized medicine objectives.
CONTACT: Investor Contact: David Burke The Ruth Group 646-536-7009 dburke@theruthgroup.com
Help employers find you! Check out all the jobs and post your resume.